You are here: Industry Insights > Cancer

News List

FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extens fda
December 01, 2017
FDA approves test to detect mutations in 324 genes, two genomic signatures. Second to be approved with proposed coverage under FDA/CMS Parallel Review Program.
Takeda spins off cancer assets to incubated startup fiercebiotech
November 23, 2017
The resulting biotech, Chordia Therapeutics, starts life with multiple oncology drugs, lab space at a Takeda site and funding from the Japanese firm and a VC syndicate.
LLS funds $46 Million in new research to find cures for cancer biospectrumasia
November 23, 2017
More than a dozen blood cancer therapies FDA approved in 2017 are a testament to LLS's impact on the cancer landscape.
Study shows Public has low awareness of obesity cancer link pharmatimes
November 21, 2017
New research shows that public awareness of the risks of obesity and its links with cancer continues to be low, according to a study published in the Journal of Public Health.
Singapore’s National Cancer Centre partners with immunoSCAPE to improve cancer treatments biospectrumasia
November 09, 2017
Both parties have said in a joint release that several projects in prostate, head and neck, lung and urogenital cancers are already in discussion.
Carbon nanotubes may pose cancer risk similar to asbestos europeanpharmaceuticalreview
November 08, 2017
A study has provided strong evidence that certain carbon nanotubes used in manufacturing could pose the same cancer risk as asbestos…
Can cannabinoids be used to treat cancer? worldpharmanews
November 07, 2017
When cannabinoids activate signaling pathways in cancer cells they can stimulate a cell death mechanism called apoptosis, unleashing a potent anti-tumor effect.
FDA Warns Companies Marketing Unproven Products, Derived From Marijuana, That Claim To Treat, Cure C americanpharmaceuticacreview
November 03, 2017
The U.S. Food and Drug Administration has issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these outcomes.
New 'Double Decker' Antibody Technology Fights Cancer biospectrumasia
October 27, 2017
The new ADC technology advances a class of pharmaceuticals that use antibodies to selectively deliver drugs to cancer cells without harming healthy cells and tissues.
Cancer Vanguard, Amgen develop commissioning toolkit pharmatimes
October 25, 2017
The Cancer Vanguard and Amgen have developed a simulation modelling tool to show health commissioners and trusts the financial benefits and challenges of delivering breast cancer medicines in a variety of community settings.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page